147 related articles for article (PubMed ID: 33884469)
1. Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer.
Rachner TD; Kasimir-Bauer S; Goebel A; Erdmann K; Hoffmann O; Rauner M; Hofbauer LC; Kimmig R; Bittner AK
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2233-2238. PubMed ID: 33884469
[TBL] [Abstract][Full Text] [Related]
2. Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.
Yang S; Cheng H; Huang Z; Wang X; Wan Y; Cai J; Wang Z
Dis Markers; 2015; 2015():506428. PubMed ID: 25873749
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis.
Klotz DM; Kuhlmann JD; Link T; Goeckenjan M; Hofbauer LC; Göbel A; Rachner TD; Wimberger P
Front Oncol; 2022; 12():974885. PubMed ID: 36338759
[TBL] [Abstract][Full Text] [Related]
4. Soluble Neuropilin-1 Is Elevated in Sepsis and Correlates with Organ Dysfunction and Long-Term Mortality in Critical Illness.
Hohlstein P; Schumacher E; Abu Jhaisha S; Adams JK; Pollmanns MR; Schneider CV; Hamesch K; Horvathova K; Wirtz TH; Tacke F; Trautwein C; Weiskirchen R; Koch A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791476
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 Associated Molecules in the Blood Distinguish Poor Prognosis Breast Cancer: A Cross-Sectional Study.
Naik A; Al-Zeheimi N; Bakheit CS; Al Riyami M; Al Jarrah A; Al Moundhri MS; Al Habsi Z; Basheer M; Adham SA
Sci Rep; 2017 Jun; 7(1):3301. PubMed ID: 28607365
[TBL] [Abstract][Full Text] [Related]
6. Serum and tissue expression of neuropilin 1 in precancerous and malignant vocal fold lesions.
Rzepakowska A; Żurek M; Grzybowski J; Kotula I; Pihowicz P; Górnicka B; Demkow U; Niemczyk K
PLoS One; 2020; 15(10):e0239550. PubMed ID: 33002021
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
[TBL] [Abstract][Full Text] [Related]
8. Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancer.
Di Gioia D; Dresse M; Mayr D; Nagel D; Heinemann V; Stieber P
Clin Chim Acta; 2015 Feb; 440():16-22. PubMed ID: 25444743
[TBL] [Abstract][Full Text] [Related]
9. Relationship between neuropilin-1 expression and prognosis, according to gastric cancer histology.
Seo HS; Hyeon J; Song IH; Lee HH
J Mol Histol; 2020 Apr; 51(2):199-208. PubMed ID: 32242307
[TBL] [Abstract][Full Text] [Related]
10. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
[TBL] [Abstract][Full Text] [Related]
11. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis.
Chora I; Romano E; Manetti M; Mazzotta C; Costa R; Machado V; Cortez A; Bruni C; Lepri G; Guiducci S; De Paulis A; Soares R; Matucci-Cerinic M
J Rheumatol; 2017 Aug; 44(8):1190-1197. PubMed ID: 28507177
[TBL] [Abstract][Full Text] [Related]
13. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
[TBL] [Abstract][Full Text] [Related]
14. High serum levels of periostin are associated with a poor survival in breast cancer.
Rachner TD; Göbel A; Hoffmann O; Erdmann K; Kasimir-Bauer S; Breining D; Kimmig R; Hofbauer LC; Bittner AK
Breast Cancer Res Treat; 2020 Apr; 180(2):515-524. PubMed ID: 32040688
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
17. L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
Wu JD; Hong CQ; Huang WH; Wei XL; Zhang F; Zhuang YX; Zhang YQ; Zhang GJ
Clin Breast Cancer; 2018 Oct; 18(5):e851-e861. PubMed ID: 29510897
[TBL] [Abstract][Full Text] [Related]
18. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
19. Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer.
Aharinejad S; Salama M; Paulus P; Zins K; Berger A; Singer CF
Endocr Relat Cancer; 2013 Dec; 20(6):777-83. PubMed ID: 24016870
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.
Seong MK; Lee JY; Byeon J; Sohn YJ; Seol H; Lee JK; Kim EK; Kim HA; Noh WC
Breast Cancer Res Treat; 2015 Feb; 150(1):141-8. PubMed ID: 25682076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
